NEWS & MEDIA

Happy New Year from the StemTek team

Bilbao, Spain - December 30, 2015

From StemTek Therapeutics we want to send a big Happy New Year to all the patients and families that are fighting against cancer in these emotive days. We remember those that unfortunately will not be around in 2016, this is for you! We restlessly continue our fight and our commitment to beat cancer, we are here for you, StemTek is open for Christmas!! Happy 2016!!!   Desde StemTek queremos felicitar el nuevo año muy especialmente a tod@s los que de alguna manera se e...

The Cancer “Queen” Cell

Bilbao, Spain - December 21, 2015

“Most people (about 80 percent according to one survey) try to control fire ants by treating individual mounds. Mound treatments are expensive, up to $2 or more per mound, and require lots of time and labor if you have much land to treat. You can easily use too much insecticide, which may lead to environmental contamination if rain washes the insecticide into lakes and streams. To be effective, the mound treatment must kill the queen(s). Otherwise, the colony will survive. Some nests ma...
StemTek Therapeutics, a leading Spanish biotech start up with a stem cell centric approach, today announced an important collaboration with the Institute for Advanced Chemistry of Catalonia (IQAC) part of the Spanish National Research Council (CSIC). The agreement enables greater access and deeper collaboration between the private and the public sector to screen libraries of compounds from the Institute for Advanced Chemistry of Catalonia in order to identify those that can be used ...
In this interview, Eva Caballero talks about the recent news from Silicon Valley about the estratosfera valuation of Stemcntrx, start up dedicated to drug development in cancer targeting cancer stem cells. Angel Garcia Martin talks about how cancer stem cells are indeed a new frontier for anti-cancer drug development and how noe there is a revamped interest in pharma industry for novel therapeutics that control the growth of these populations. This is precisely the mission of StemTek The...

Silicon Valley Invests Big in Cancer Stem Cells

Bilbao, Spain - September 08, 2015

Three billion dollars, largest valuation for a biotech start-up that targets cancer stem cells. We just read in MIT Technology Review that Silicon Valley heavyweights Peter Thiel and Elon Musk, investor and CEO of Tesla, just invested in an unheard of biotech start up which represents the biggest biotech valuation to date aimed at cancer stem cell treatments. Peter Thiel, one of the first outside investors in Facebook, just invested $200 million into Stemcentrx, his fund’s la...
Back to top